Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma
Clinical trial NCT05433142 · RECRUITING
Trial details
- NCT number
- NCT05433142
- Sponsor
- Xencor, Inc.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-13
- Primary completion
- 2027-02-01
- Enrollment
- 307
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.